SULT2B1 and ovarian carcinoma: Similarly, SULT2B1 is also reported to be expressed at a high level in endometrial cancer, cervical cancer, and ovarian cancer, which negatively impacts prognosis (Dumas et al., 2008; Low et al., 2010; Hevir et al., 2011; Zhang Y. et al., 2023; Gao et al., 2024).